Regulation of emergency hematopoiesis by the ubiquitin-proteasome system

泛素-蛋白酶体系统对紧急造血的调节

基本信息

  • 批准号:
    10634676
  • 负责人:
  • 金额:
    $ 62.79万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-01 至 2025-05-31
  • 项目状态:
    未结题

项目摘要

Project Summary The response to systemic infection and tissue injury requires the rapid adaptation of hematopoietic stem cells (HSCs) in the bone marrow, which proliferate and divert their differentiation towards the myeloid lineage. Significant interest has emerged in understanding the signals that trigger this emergency hematopoietic program. However, the mechanisms that terminate this response of the HSCs and restore tissue homeostasis remain unknown. The clinical success of proteasome inhibitors, bortezomib, and E3 ubiquitin ligase glues for the treatment of hematologic diseases has made the Ubiquitin pathway a bona fide target for cancer therapeutics. Thus, defining how novel E3 ligases function in the bone marrow and investigating their specific roles in normal and emergency hematopoiesis can lead to novel therapeutic interventions. We have demonstrated that the E3 ubiquitin ligase Spop restrains the inflammatory activation of HSCs. In the absence of Spop, systemic inflammation proceeds in an unresolved manner and the sustained response in the HSCs results in a lethal phenotype reminiscent of hyper-inflammatory syndrome. Our proteomic/biochemical studies demonstrated that Spop restricts inflammation by targeting the signal transducer Myd88 for proteasome-dependent degradation. Myd88 accumulation in conjunction with an inflammatory stimulus leads to Myddosome formation, the hyper-phosphorylation of the Irak4 kinase and activation of a number of transcription factor pathways (NF-kB, Jun, Pu.1, Cebpb). This proposal defines: (a) the transcriptional and chromatin landscape changes imposed during initiation and termination of emergency hematopoiesis in the bone marrow HSC and progenitor cells, (b) the role of the myddosome assembly, signaling and termination in emergency hematopoiesis and gene regulation and (c) the structural details of myddosome assembly and termination. The findings of this grant proposal will uncover HSC-intrinsic mechanisms essential for reestablishing homeostasis following emergency hematopoiesis.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Iannis Aifantis其他文献

Iannis Aifantis的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Iannis Aifantis', 18)}}的其他基金

The role of inflammation in the regulation of immune response in acute myeloid leukemia
炎症在急性髓系白血病免疫反应调节中的作用
  • 批准号:
    10729281
  • 财政年份:
    2023
  • 资助金额:
    $ 62.79万
  • 项目类别:
Dissecting innate immune signaling in pre-leukemia evolution
剖析白血病前期进化中的先天免疫信号
  • 批准号:
    10584536
  • 财政年份:
    2022
  • 资助金额:
    $ 62.79万
  • 项目类别:
Dissecting innate immune signaling in pre-leukemia evolution
剖析白血病前期进化中的先天免疫信号
  • 批准号:
    10462192
  • 财政年份:
    2022
  • 资助金额:
    $ 62.79万
  • 项目类别:
mRNA stability and its impact on hematopoiesis and acute leukemia
mRNA稳定性及其对造血和急性白血病的影响
  • 批准号:
    10339742
  • 财政年份:
    2022
  • 资助金额:
    $ 62.79万
  • 项目类别:
mRNA stability and its impact on hematopoiesis and acute leukemia
mRNA稳定性及其对造血和急性白血病的影响
  • 批准号:
    10543125
  • 财政年份:
    2022
  • 资助金额:
    $ 62.79万
  • 项目类别:
Regulation of emergency hematopoiesis by the ubiquitin-proteasome system
泛素-蛋白酶体系统对紧急造血的调节
  • 批准号:
    10279596
  • 财政年份:
    2021
  • 资助金额:
    $ 62.79万
  • 项目类别:
Mechanisms of enhancer regulation in leukemia
白血病增强子调控机制
  • 批准号:
    10545714
  • 财政年份:
    2019
  • 资助金额:
    $ 62.79万
  • 项目类别:
Project 3: Oncogenic triggers and their influence on 3D chromosomal architecture
项目 3:致癌触发因素及其对 3D 染色体结构的影响
  • 批准号:
    10652283
  • 财政年份:
    2019
  • 资助金额:
    $ 62.79万
  • 项目类别:
Developmental Research Program
发展研究计划
  • 批准号:
    10434092
  • 财政年份:
    2019
  • 资助金额:
    $ 62.79万
  • 项目类别:
Mechanisms of enhancer regulation in leukemia
白血病增强子调控机制
  • 批准号:
    10321638
  • 财政年份:
    2019
  • 资助金额:
    $ 62.79万
  • 项目类别:

相似海外基金

Elucidating the biophysics of pre-fibrillar, toxic tau oligomers: from amino acid motifs to neuronal dysfunction
阐明前原纤维有毒 tau 寡聚体的生物物理学:从氨基酸基序到神经元功能障碍
  • 批准号:
    10461322
  • 财政年份:
    2021
  • 资助金额:
    $ 62.79万
  • 项目类别:
Elucidating the biophysics of pre-fibrillar, toxic tau oligomers: from amino acid motifs to neuronal dysfunction
阐明前原纤维有毒 tau 寡聚体的生物物理学:从氨基酸基序到神经元功能障碍
  • 批准号:
    10489810
  • 财政年份:
    2021
  • 资助金额:
    $ 62.79万
  • 项目类别:
Detection of amino acid motifs on the agretopes of antigens highly bound to MHC molecules
检测与 MHC 分子高度结合的抗原聚集位上的氨基酸基序
  • 批准号:
    03670243
  • 财政年份:
    1991
  • 资助金额:
    $ 62.79万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了